Loading...
Long‐Term Efficacy and Safety of Triple‐Combination Therapy With Olmesartan Medoxomil and Amlodipine Besylate and Hydrochlorothiazide for Hypertension
J Clin Hypertens (Greenwich). 2012;14:149–157. ©2012 Wiley Periodicals, Inc. Most patients with hypertension require combination therapy in order to achieve blood pressure (BP) goals. This 40‐week open‐label extension of the 12‐week double‐blind Triple Therapy With Olmesartan Medoxomil, Amlodipine,...
Na minha lista:
| Udgivet i: | J Clin Hypertens (Greenwich) |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Blackwell Publishing Ltd
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8108825/ https://ncbi.nlm.nih.gov/pubmed/22372774 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1751-7176.2011.00588.x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|